Correlation between Polypharmacy and Length of Stay Geriatric Patient

Abstract

Introduction

Polypharmacy, the concurrent use of five or more medications, is a growing concern in geriatric care due to the rising prevalence of multimorbidity. This practice is associated with adverse health outcomes, including frailty and increased hospitalization. Understanding the correlation between polypharmacy and the length of hospital stay is critical for optimizing treatment and improving healthcare efficiency for aging populations. This review synthesizes literature on this complex relationship.

Methods

This abstract is based on a literature review synthesizing findings from narrative reviews, systematic reviews, and meta-analyses. The review examined the association between polypharmacy and health outcomes in geriatric patients, focusing on its impact on hospitalization rates, length of stay, frailty, and the role of medication management interventions.

Results

The literature establishes a strong link between polypharmacy and adverse health outcomes in the elderly. Polypharmacy is associated with an increased risk of mortality, emergency department visits, and hospitalization, particularly in frail or prefrail individuals. Studies demonstrate a dose-response relationship, where a higher number of medications corresponds to worse outcomes. Polypharmacy is also linked to potentially inappropriate prescribing (PIP), which can elevate healthcare costs and health complications. Effective interventions, primarily medication reviews, have been shown to be crucial in managing polypharmacy and mitigating its negative effects.

Discussion

The evidence confirms that polypharmacy is a significant risk factor for prolonged hospital stays and increased healthcare utilization among geriatric patients. The interplay with frailty creates a cycle where multiple medications can exacerbate vulnerability, leading to hospitalization. The wide variance in polypharmacy prevalence suggests that prescribing practices and healthcare systems play a significant role. While medication reviews are a pivotal strategy, addressing barriers to their implementation in clinical settings is essential for translating research into effective practice.

Conclusion

A clear correlation exists between polypharmacy and increased length of stay for geriatric patients. This relationship is driven by a higher risk of adverse drug events, frailty, and hospitalization. Comprehensive strategies, centered around systematic medication reviews, are urgently needed to optimize medication regimens, improve health outcomes, reduce healthcare costs, and enhance the quality of life for this vulnerable population.